Back to results
US 2017/0304459 A1Published application
Methods and compositions for inhalation delivery of conjugated oligonucleotide
AssigneeAlnylam Pharmaceuticals, Inc.
InventorsVasant JADHAV, Martin MAIER, Laura SEPP-LORENZINO
Life of this patent
Estimating the term…
Abstract
The present invention provides an inhalable formulation comprising a ligand conjugated oligonucleotide and particles of a physiologically acceptable pharmacologically-inert carrier.
Claims27
An inhalable formulation comprising a ligand-conjugated oligonucleotide and particles of a physiologically acceptable pharmacologically-inert carrier.
Dependencies are inferred from the claim text.